Insider Trading Activity ABIOMED, Inc. (NASDAQ:ABMD) – Director Sold 10,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For ABIOMED, Inc. (NASDAQ:ABMD)

Paul Thomas , Director of ABIOMED, Inc. (NASDAQ:ABMD) reportedly Sold 10,000 shares of the company’s stock at an average price of 154.71 for a total transaction amount of $1,547,100.00 SEC Form

Insider Trading History For ABIOMED, Inc. (NASDAQ:ABMD)

  • On 2/25/2013 Henri A Termeer, Director, bought 100,000 with an average share price of $14.98 per share and the total transaction amounting to $1,498,000.00.View SEC Filing
  • On 5/7/2013 Henri A Termeer, Director, bought 100,000 with an average share price of $19.86 per share and the total transaction amounting to $1,986,000.00.View SEC Filing
  • On 5/9/2013 Michael R Minogue, CEO, sold 20,000 with an average share price of $21.00 per share and the total transaction amounting to $420,000.00.View SEC Filing
  • On 5/17/2013 Robert Bowen, CFO, sold 2,715 with an average share price of $23.50 per share and the total transaction amounting to $63,802.50.View SEC Filing
  • On 5/23/2013 Michael R Minogue, CEO, sold 5,666 with an average share price of $21.62 per share and the total transaction amounting to $122,498.92.View SEC Filing
  • On 5/23/2013 Andrew J Greenfield, VP, sold 1,666 with an average share price of $21.63 per share and the total transaction amounting to $36,035.58.View SEC Filing
  • On 5/28/2013 William J Bolt, SVP, sold 4,629 with an average share price of $22.18 per share and the total transaction amounting to $102,671.22.View SEC Filing

    • Analyst Ratings For ABIOMED, Inc. (NASDAQ:ABMD)
    These are 1 Hold Rating, 6 Buy Ratings .
    The current consensus rating for ABIOMED, Inc. (NASDAQ:ABMD) is Buy (Score: 2.86) with a consensus target price of $157.50 , a potential (2.47% upside)

    Analyst Ratings History For ABIOMED, Inc. (NASDAQ:ABMD)

    • On 8/17/2015 CRT Capital Initiated Coverage of rating Buy
    • On 10/29/2015 Sterne Agee CRT Reiterated Rating Buy
    • On 10/30/2015 Raymond James Financial, Inc. Upgraded rating Market Perform to Outperform with a price target of $85.00
    • On 4/10/2016 Benchmark Co. Reiterated Rating Buy with a price target of $145.00
    • On 12/6/2016 Guggenheim Initiated Coverage of rating Buy with a price target of $150.00
    • On 1/8/2017 BTIG Research Reiterated Rating Buy with a price target of $170.00
    • On 3/30/2017 Leerink Swann Boost Price Target of rating Outperform with a price target of $140.00 to $150.00

    Recent Trading Activity for ABIOMED, Inc. (NASDAQ:ABMD)
    Shares of ABIOMED, Inc. closed the previous trading session at 153.70 down -1.46 -0.94% with 124,882 shares trading hands.